VNRX - VolitionRX: Cancer Diagnostic Tool For Our Best Friends

• VolitionRX develops and sells a simple and cost effective blood test to detect cancers and other serious diseases in our best friends, dogs.
• The potential market is huge, with 77 millions dogs in the U.S., and 83% of which visit a vet at lease once a year.
• Their test can identify 77% of lymphomas and 82% of hemangiosarcoma (types of cancers).
• Their technology is well protected by patents.

For further details see: